MDL 63246: a semisynthetic glycopeptide; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 17748716 |
| MeSH ID | M0254136 |
| Synonym |
|---|
| mdl-63246 |
| H3YYY0ENVA , |
| ristomycin a aglycone, 5,31-dichloro-38-de(methoxycarbonyl)-7-demethyl-19-deoxy-56-o-(2-deoxy-2-((10-methyl-1-oxoundecyl)amino)-.beta.-d-glucopyranosyl)-38-(((3-(dimethylamino)propyl)amino)carbonyl)-42-o-.alpha.-d-mannopyranosyl-n15-methyl- |
| 148868-06-8 |
| mdl-63,246 |
| mdl 63246 |
| mdl 63,246 |
| ristomycin a aglycone, 5,31-dichloro-38-de(methoxycarbonyl)-7-demethyl-19-deoxy-56-o-(2-deoxy-2-((10-methyl-1-oxoundecyl)amino)-beta-d-glucopyranosyl)-38-(((3-(dimethylamino)propyl)amino)carbonyl)-42-o-alpha-d-mannopyranosyl-n15-methyl- |
| Q27279610 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.15) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||